GlassScriptPhysician profile
Morad Nasseri
NPI 1154615565
$90,701.94
in general payments reported to CMS, 2019-2025
32 companies · $34K in 2025
The $34K reported for 2025 was more than what 95% of Neurology (Psychiatry & Neurology) providers received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $170 · 2020: $644 · 2021: $1,252 · 2022: $11K · 2023: $21K · 2024: $23K · 2025: $34K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $36K · Travel and Lodging: $19K · Food and Beverage: $14K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,850 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,725 · Education: $16.33.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $36,455.00 |
| Travel and Lodging | $18,916.99 |
| Food and Beverage | $13,647.26 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,850.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,725.00 |
| Education | $16.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $26,713.23 | 2023-2025 | Evoke, Evoke Scs |
| Nevro Corp. | $26,029.40 | 2021-2024 | Senza |
| Abbott Laboratories | $7,946.31 | 2020-2025 | Proclaim, Eterna, Amplatzer Talisman |
| Globus Medical, INC. | $7,263.24 | 2025 | Senza, Creo |
| Si-Bone, INC. | $3,496.39 | 2022-2025 | |
| Medtronic, INC. | $2,940.46 | 2022-2025 | Synchromedii, Intellis Adaptivestim |
| Spinal Simplicity, LLC | $2,827.47 | 2022-2025 | Ha Minuteman G3-R |
| Boston Scientific Corporation | $2,758.77 | 2020-2025 | Wavewriter Alpha Prime 16, Intracept, Superion Indirect Decompression System |
| Painteq LLC | $1,798.25 | 2022-2024 | Painteq |
| Relievant Medsystems, INC. | $1,696.04 | 2021-2023 | Intracept |
| Spr Therapeutics, INC | $1,473.42 | 2021-2025 | Sprint Pns System |
| Nalu Medical, INC. | $1,175.26 | 2022-2025 | Nalu Neurostimulation System |
| Biotronik Nro, INC. | $1,012.24 | 2023-2025 | Prospera, Biotronik |
| Mml US, INC. | $979.42 | 2024-2025 | Reactiv8 |
| Curonix LLC | $785.92 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $338.73 | 2022-2025 | |
| Alexion Pharmaceuticals, INC. | $264.97 | 2019-2020 | |
| Vertos Medical, INC. | $224.15 | 2022-2023 | Mild Device Kit |
| Bioventus LLC | $188.62 | 2022-2024 | Durolane |
| Mesoblast, INC. | $177.57 | 2025 | Ryoncil |
| Lilly USA, LLC | $121.84 | 2020 | |
| Foundation Fusion Solutions, LLC | $73.15 | 2023-2024 | |
| Biohaven Pharmaceutical Holding Company LTD. | $72.45 | 2022 | |
| Stimwave Technologies Incorporated | $69.00 | 2021 | |
| Collegium Pharmaceutical, INC. | $64.24 | 2021-2023 | Belbuca |
| Electronic Waveform Lab, INC. | $45.41 | 2022 | |
| Grt US Holding, INC. | $44.61 | 2022 | |
| Scilex Pharmaceuticals INC. | $39.30 | 2022-2023 | Ztlido |
| Pfizer INC. | $36.03 | 2023-2025 | |
| Fidia Pharma USA INC. | $19.39 | 2022 | |
| Genzyme Corporation | $13.69 | 2019 | |
| Genentech USA, INC. | $12.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morad Nasseri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.